The EPS projection of AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) for period quarter completed 2016-12-31 is $0.52.
The EPS estimates pronounced a week and 30 days ago were $0.52 and $0.52 correspondingly. The EPS forecasts specified 60 and 90 days before were $0.52 and $0.52 respectively. From a week ago, the aberration in EPS forecast is 0 percent.
The mean EPS prediction straightaway before the earnings release for the quarter completed 2 is $0.52 based on 4 EPS estimations. The EPS stated on 2016-08-09 was $-0.02. The EPS surprise was $-0.3, or -107.14 percent. The standard deviation as per known EPS estimates was $0.41.
The positive EPS revisions were 0 a week earlier and negative revisions were 0. In last 30 and 60 days, the positive EPS revisions were 0 and 0 correspondingly, while for 90 and 120 days, revisions count was 0 and 0.
The negative revisions of per-share earnings in the last 30 and 60-days were 0 and 2 in that order. however, for 90 and 120 days’ period, the count was 2 and 2 in that order.
EPS revisions upgrade and downgrade in the last 18 days were 0 and 1 correspondingly.
Quarterly Sales Estimates
The arithmetic mean of probable annual sales of AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) is $178.456 and the median was $178.456. The estimate is stated by 2 analysts for the fiscal 2017.
The highest annual projection is $180.1 and lowest sales target is $176.812. This marks a standard deviation of $2.324.
Almost 2 have given revised positive sales forecast in the past week and 2 have downgraded forecasts. As per the stated estimates, the change in target from the past week is 0 percent.
Nearly 2 have revised sales projections in positive side over the past month and 2 have downgraded forecasts. This shows a mean estimate deviation of 0 percent.
Just about 2 have revised sales forecast on plus side over the quarter and 2 have downgraded forecasts. This shows mean estimate deviation of -0.192 percent.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...